Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors' reply

Affiliations

¹ Department of Gastroenterology, University Hospital Southampton, Southampton, UK.
² Department of Research and Development, Bristol Royal Infirmary, Bristol, UK.
³ Institute of Biosensing Technology, University of the West of England, Bristol, UK.
⁴ Institute of Biosensing Technology, University of the West of England, Bristol, UK. norman.ratcliffe@uwe.ac.uk.
⁵ Gastroenterology Research Unit, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

Comment

I Ahmed et al. Aliment Pharmacol Ther. 2016 Jun.

. 2016 Jun;43(11):1241-2.

doi: 10.1111/apt.13617.

¹ Department of Gastroenterology, University Hospital Southampton, Southampton, UK.
² Department of Research and Development, Bristol Royal Infirmary, Bristol, UK.
³ Institute of Biosensing Technology, University of the West of England, Bristol, UK.
⁴ Institute of Biosensing Technology, University of the West of England, Bristol, UK. norman.ratcliffe@uwe.ac.uk.
⁵ Gastroenterology Research Unit, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

No abstract available

Comment on

Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease.
Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS. Ahmed I, et al. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25. Aliment Pharmacol Ther. 2016. PMID: 26806034
Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease.
Furnari M, Bodini G, Giannini EG, Savarino V. Furnari M, et al. Aliment Pharmacol Ther. 2016 Jun;43(11):1240-1. doi: 10.1111/apt.13581. Aliment Pharmacol Ther. 2016. PMID: 27137728 No abstract available.